What is Methylprednisolone?
Category: Prescription Drugs
Most popular types: Solu-Medrol Infusion Solu-Medrol Medrol Show all
Methylprednisolone is a synthetic corticosteroid drug used primarily as an anti-inflammatory or immunosuppressant agent for diseases of hematologic, allergic, inflammatory, neoplastic, and autoimmune origin; also for graft-versus-host disease.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Systemic lupus erythematosus | 1438 | 14 | |
| Multiple sclerosis | 614 | 362 | |
| Chronic obstructive pulmonary disease | 403 | 7 | |
| Prevent organ rejection | 221 | 18 | |
| Optic neuritis | 90 | 35 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 144 | |
| Moderate | 307 | |
| Mild | 271 | |
| None | 210 |
Commonly reported side effects and conditions associated with Methylprednisolone
| Side effect | Patients | Percentage |
|---|---|---|
| Insomnia | 77 | |
| Metallic taste in mouth | 71 | |
| Weight gain | 62 | |
| Increased appetite | 45 | |
| Headaches | 41 | |
| Change in taste | 39 |
Why patients stopped taking Methylprednisolone
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Course of treatment ended | 1011 | |
| Doctor's advice | 176 | |
| Did not seem to work | 89 | |
| Side effects too severe | 86 | |
| Other | 78 | |
| Change in health plan coverage | 9 | |
| Personal research | 9 | |
| Expense | 4 |
Duration
Stopped taking Methylprednisolone
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 855 | |
| 1 - 6 months | 130 | |
| 6 months - 1 year | 82 | |
| 1 - 2 years | 70 | |
| 2 - 5 years | 82 | |
| 5 - 10 years | 51 | |
| 10 years or more | 35 |
What people switch to and from
Patients started taking Methylprednisolone after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Prednisone (Prednisone Intensol) | 19 | |
| Dimethyl fumarate (Tecfidera) | 3 | |
| Methotrexate (Apo-Methotrexate) | 3 | |
| Hydroxychloroquine (Plaquenil) | 2 | |
| Intravenous Immunoglobulin (IVIG) (Gammaglobulin (IVIg)) | 2 |
Patients stopped taking Methylprednisolone and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Prednisone (Prednisone Intensol) | 15 | |
| Corticotropin (Acthar Gel HP) | 5 | |
| Intravenous Immunoglobulin (IVIG) (Gammaglobulin (IVIg)) | 4 | |
| Rituximab (Rituxan) | 4 | |
| Hydroxychloroquine (Plaquenil) | 3 |
Last updated: